|
(11) | EP 3 829 714 A1 |
| (12) |
|
|
|
|
|||||||||||||||||||||||||||
| (54) | ORAL NUTRACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF METABOLIC SYNDROME |